132980-17-7

MMAI is a psychoactive aminoindan which can be found in recreational drug mixtures. It potently inhibits serotonin uptake (IC₅₀ = 212 nM) and stimulates its release without inducing the neurotoxicity induced by 3,4-methylenedioxy methamphetamine and similar compounds. This product is intended for forensic and research applications.

2,3-Dihydro-5-methoxy-6-methyl-1H-inden-2-amine is an highly selective serotonin releasing agent and produces entactogen effects.

[1] P.D. SAINSBURY. Aminoindanes—the next wave of ‘legal highs’?[J]. Drug Testing and Analysis, 2011, 3 7-8: 479-482. DOI: 10.1002/dta.318
[2] MICHAEL P. JOHNSON. Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA)[J]. Journal of Medicinal Chemistry, 1991, 34 5: 1662-1668. DOI: 10.1021/jm00109a020